Results

RDF/XMLNTriplesTurtleShow queryShare ▶
SubjectPredicateObject
http://purl.uniprot.org/citations/26584135http://www.w3.org/1999/02/22-rdf-syntax-ns#typehttp://purl.uniprot.org/core/Journal_Citation
http://purl.uniprot.org/citations/26584135http://www.w3.org/2000/01/rdf-schema#comment"

Background and aims

Monoglyceride lipase (MGL) catalyzes the final step of lipolysis by degrading monoglyceride (MG) to glycerol and fatty acid. MGL also hydrolyzes and thereby deactivates 2-arachidonoyl glycerol (2-AG), the most abundant endocannabinoid in the mammalian system. 2-AG acts as full agonist on cannabinoid receptor type 1 (CB1R) and CB2R, which are mainly expressed in brain and immune cells, respectively. Thus, we speculated that in the absence of MGL, increased 2-AG concentrations mediate CB2R signaling in immune cells to modulate inflammatory responses, thereby affecting the development of atherosclerosis.

Methods and results

We generated apolipoprotein E (ApoE)/MGL double-knockout (DKO) mice and challenged them with Western-type diet for 9 weeks. Despite systemically increased 2-AG concentrations in DKO mice, CB2R-mediated signaling remains fully functional, arguing against CB2R desensitization. We found increased plaque formation in both en face aortae (1.3-fold, p = 0.028) and aortic valve sections (1.5-fold, p = 0.0010) in DKO mice. Interestingly, DKO mice also presented reduced lipid (12%, p = 0.031) and macrophage content (18%, p = 0.061), elevated intraplaque smooth muscle staining (1.4-fold, p = 0.016) and thicker fibrous caps (1.8-fold, p = 0.0032), together with a higher ratio of collagen to necrotic core area (2.5-fold, p = 0.0003) and expanded collagen content (1.6-fold, p = 0.0007), which suggest formation of less vulnerable atherosclerotic plaques. Treatment with a CB2R inverse agonist prevents these effects in DKO mice, demonstrating that the observed plaque phenotype in DKO mice originates from CB2R activation.

Conclusion

Loss of MGL modulates endocannabinoid signaling in CB2R-expressing cells, which concomitantly affects the pathogenesis of atherosclerosis. We conclude that despite larger lesion size loss of MGL improves atherosclerotic plaque stability. Thus, pharmacological MGL inhibition may be a novel intervention to reduce plaque rupture."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.org/dc/terms/identifier"doi:10.1016/j.atherosclerosis.2015.10.109"xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Zimmermann R."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Eichmann T.O."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Goeritzer M."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Kratky D."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Lass A."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Hoefler G."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Schauer S."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Graier W.F."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Madreiter-Sokolowski C.T."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Schlager S."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Rainer S."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Rosenberger A."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Radovic B."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Doddapattar P."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Vujic N."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/author"Woelfler A."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/date"2016"xsd:gYear
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/name"Atherosclerosis"xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/pages"9-21"xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/title"Monoglyceride lipase deficiency modulates endocannabinoid signaling and improves plaque stability in ApoE-knockout mice."xsd:string
http://purl.uniprot.org/citations/26584135http://purl.uniprot.org/core/volume"244"xsd:string
http://purl.uniprot.org/citations/26584135http://www.w3.org/2004/02/skos/core#exactMatchhttp://purl.uniprot.org/pubmed/26584135
▶